Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
Recruiting now · Phase 1/Phase 2
Conditions studied: Metastatic Prostate Cancer
In brief
The main purpose of this study is to assess the safety and tolerability of AZD0516 as monotherapy and/or in combination with other anti-cancer agents for treatment of metastatic prostate cancer.
Key facts
- Study ID
- NCT07181161
- Run by
- AstraZeneca
- People needed
- 177
- Starts
- 2025-10-01
- Expected to finish
- 2029-01-18
- Last updated by the study team
- 2026-07-15
Who can join
Age: 18 and older, up to 130. Sex: male. Healthy volunteers: not accepted.
Where it is running
- Research Site — Pamplona, Spain (enrolling)
- Research Site — Detroit, Michigan, United States (enrolling)
- Research Site — Seoul, South Korea (enrolling)
- Research Site — Madrid, Spain (enrolling)
- Research Site — Plymouth, United Kingdom (enrolling)
- Research Site — Cambridge, United Kingdom (enrolling)
- Research Site — Los Angeles, California, United States (enrolling)
- Research Site — Kōtoku, Japan (enrolling)
- Research Site — Seoul, South Korea (enrolling)
- Research Site — Barcelona, Spain (enrolling)
- Research Site — London, United Kingdom (enrolling)
- Research Site — London, United Kingdom (enrolling)
- Research Site — Fayetteville, Arkansas, United States (enrolling)
- Research Site — Sutton, United Kingdom (enrolling)
- Research Site — New York, New York, United States (enrolling)
- Research Site — Boston, Massachusetts, United States (enrolling)
- Research Site — Providence, Rhode Island, United States (enrolling)
- Research Site — Chūōku, Japan (enrolling)
- Research Site — Myrtle Beach, South Carolina, United States (enrolling)
- Research Site — Ann Arbor, Michigan, United States (enrolling)
- Research Site — Houston, Texas, United States (enrolling)
- Research Site — Seoul, South Korea (enrolling)
- Research Site — Changsha, China
- Research Site — São Paulo, Brazil
- Research Site — Porto Alegre, Brazil
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.